BMJ  2008;336:851 (19 April), doi:10.1136/bmj.39552.538356.DB

News

Germany liberalises law on stem cell research

Ned Stafford

1 Hamburg

The first 150 words of the full text of this article appear below.

After months of often impassioned public debate Germany’s Bundestag has voted to liberalise the nation’s law on research involving embryonic stem cells. Researchers say that the change will allow them to more effectively compete—and collaborate—internationally.

The revised law, approved on 11 April, will allow German scientists to import stem cell lines derived from embryos before 1 May 2007, although the process to derive stem cells will still be banned in Germany. Under the old law the import cut-off date was 1 January 2002, meaning that scientists had access to only about 40 outdated stem cell lines. Now they will be able to work with more than 400 lines.

Jürgen Hescheler, head of the Institute of Neurophysiology at the University of Cologne and president of the German Society for Stem Cell Research, said that he would have preferred no cut-off date. But he admitted that he was happy with the compromise: . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview